Ticlopidine
CAS No. 55142-85-3
Ticlopidine ( —— )
产品货号. M17538 CAS No. 55142-85-3
噻氯匹定是噻吩并吡啶家族中的一种抗血小板化合物,是二磷酸腺苷 (ADP) 受体抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥223 | 有现货 |
|
| 10MG | ¥326 | 有现货 |
|
| 25MG | ¥617 | 有现货 |
|
| 50MG | ¥902 | 有现货 |
|
| 100MG | ¥1341 | 有现货 |
|
| 500MG | ¥3348 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ticlopidine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述噻氯匹定是噻吩并吡啶家族中的一种抗血小板化合物,是二磷酸腺苷 (ADP) 受体抑制剂。
-
产品描述Ticlopidine is an antiplatelet drug in the thienopyridine family which is an adenosine diphosphate (ADP) receptor inhibitor.(In Vitro):Ticlopidine exhibits activity against human CD39 with apparent Ki,app values of 14 μM.Ticlopidine inhibits recombinant human CD39 expressed in COS-7-cells with the Ki value of 127±12?μM.Growth rate is affected during the first days of culture, Ticlopidine (30 and 150 μM) reducing its effect in the following days.(In Vivo):Oral administration of Losartan with 10 mg/kg Ticlopidine significantly increases the AUC (by 65.0%), suggesting that Ticlopidine can effectively inhibit the metabolism of losartan in the intestine and/or liver.
-
体外实验Ticlopidine exhibits activity against human CD39 with apparent Ki,app values of 14 μM.Ticlopidine inhibits recombinant human CD39 expressed in COS-7-cells with the Ki value of 127±12?μM.Growth rate is affected during the first days of culture, Ticlopidine (30 and 150 μM) reducing its effect in the following days. Cell Proliferation Assay Cell Line:Human endothelial cells Concentration:30 and 150 μM Incubation Time:2, 6; 10 days Result:Treated cells grow slower if compared with controls and this effect correlates with the concentration of Ticlopidine in the culture medium.
-
体内实验Oral administration of Losartan with 10 mg/kg Ticlopidine significantly increases the AUC (by 65.0%), suggesting that Ticlopidine can effectively inhibit the metabolism of losartan in the intestine and/or liver. Animal Model:Male Sprague-Dawley rats (7-8 weeks old, weighing 270-300 g)Dosage:4 or 10 mg/kg Administration:Orally administered 30 min before oral administration of losartan.Result:The AUC and Cmax of Losartan after oral administration with Losartan and 10 mg/kg Ticlopidine were significantly greater (by 65.0% and 49.4%, respectively) than those of control rats.
-
同义词——
-
通路Angiogenesis
-
靶点EGFR
-
受体ADP
-
研究领域Others-Field
-
适应症——
化学信息
-
CAS Number55142-85-3
-
分子量263.78
-
分子式C14H14ClNS
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : ≥ 100 mg/mL (379.09 mM)
-
SMILESC1CN(Cc2c1scc2)Cc1ccccc1Cl
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Maffrand, JP (2012). Comptes Rendus Chimie. 15 (8): 737–743.
产品手册
关联产品
-
HS-10296 hydrochlori...
HS-10296 盐酸盐是一种 EGFR 激活突变和 T790M 耐药突变的小分子抑制剂,对野生型 EGFR 的活性有限。
-
Anlotinib
安罗替尼 (AL-3818) 是一种新型多靶点酪氨酸激酶,主要抑制 VEGFR2/3、FGFR1-4、PDGFR α/β、c-Kit 和 Ret。
-
Lifirafenib
在生化测定中,Lifirafenib 是 RAF 家族激酶和 EGFR 的有效抑制剂,对重组 BRAFV600E 激酶结构域、EGFR 和 EGFR T790M/L858R 突变体的 IC50 分别为 23、29 和 495 nM。
021-51111890
购物车()
sales@molnova.cn

